Thrilled to join The White House White House Office of Science & Technology Policy #ClinicalTrialsForum meeting today ‼️

Several opportunities to discuss the future of academic oncology and the challenges that we face to deliver clinical trials to our patients ❗️

Join us tomorrow #ClinicalTrialsForum

This Wednesday, June 26, at 10AM ET, White House Office of Science & Technology Policy is hosting the White House #ClinicalTrialsForum to build pathways to increase access, lower barriers to participation, and speed discovery of effective therapies. You can tune in at: youtube.com/live/EGmVHwdRx…

Congratulations to our Heme Onc fellow graduates of 2024! An amazing group of people, can’t wait to see all of the things that they do. UPMC Hematology & Oncology Fellowship Program UPMC Hillman Cancer Center

✳️ I am thrilled to share that I received David Roodman Mentoring Award last week ❗️It is a true honor❗️

✳️The most rewarding award for me, on the hand, is the growth and successes of my mentees ‼️ It is a true privilege and joy to join their journey and help their growth and

Niraparib and Dostarlimab for Patients With MMR-D/​MSI-H Colorectal Cancers

NCT06365970 opening July 2024

along with Fly me to Moon, Twisters, Didi, MaXXXine, Sound of Hope, and Despicable Me 4

Ibrahim Halil SAHIN, MD

Ibrahim Halil SAHIN, MD Congratulations and very well deserved Ibrahim Halil SAHIN, MD Thank you for all that you do for all of us UPMC Hillman Cancer Center 😇

Ibrahim Halil SAHIN, MD Dear Dr. Şahin,
Congratulations on receiving the David Roodman Mentoring Award! This is a true testament to your invaluable guidance and support.
The most rewarding aspect of having you as our mentor is the privilege and joy of growing and succeeding under your guidance.

✳️ I am thrilled to share that I received David Roodman Mentoring Award last week ❗️It is a true honor❗️

✳️The most rewarding award for me, on the hand, is the growth and successes of my mentees ‼️ It is a true privilege and joy to join their journey and help their growth and

I discussed the findings of neoadjuvant rectal cancer study of Dostarlimab with Alison Kanski - Ibrahim Halil SAHIN, MD
Precision Oncology News #CRCTrialsChat Manju George MVSc PhD Rectal Cancer Survivor Fight Colorectal Cancer UPMC Hillman Cancer Center
oncodaily.com/81075.html

#Cancer #Cancer Treatment #ColorectalCancer #OncoDaily #Oncology

Thank you Cornell University Weill Cornell Medicine for the invitation to share our work on diet, the microbiome, and immunotherapy at their intercampus immunology symposium. Such great science all week! #microbiome #womeninSTEM

The #BidenCancerMoonshot held a meeting with the Interventional Radiology community to discuss this very issue. Interventional Oncologists are impt parts of multi-disciplinary care! These procedures are minimally invasive with much shorter recovery times #ASCO24

#ASCO24 ASCO #CRCsm
♦️Some comments on CRC oral presentation from today #1 ‼️
✳️ Transmet was quite surprising data and give us hopes but several caveats in this study …
✳️First, very small study …
✳️Second, I am pleasantly surprised although 72% pts had recurrent disease

#ASCO24 ASCO #CRCsm

♦️Some comments on CRC oral presentation #4

✳️ The ARC-9 trial was quite interesting ‼️ As much as the results, the design was so interesting too, as not sure comparator arm was right choice there❓
✳️ I am not sure what was progression on OR AFTER

#ASCO24 ASCO #CRCsm

♦️Some comments on CRC oral presentation #3

✳️The CheckMate8HW sets a new bar for us for pts MSI-H (great news) but was also concerning to see 2 treatment related mortality owing to immune mediated toxicities ‼️

✳️Keynote 177 did not report any immune

#ASCO24 ASCO #CRCsm

♦️Some comments on CRC oral presentation #2

✳️Was very surprising to see how the ORCHESTRA trial showed somewhat contrary results compared to the Transmet trial ‼️

✳️Aggressive debulking for multi organ metastatic disease of CRC does not seem to be

✳️Proud of my mentee, Cyndi, who is at UPMC UPMCHillmanCC ‼️

✳️She received ASCO conquer award with her research in which she investigated the biomarker role of CDX2 among MSI-H CRC‼️
✳️Loss of CDX2 seems to be very notably more common in sporadic cases and it may predict